TuHURA Biosciences (HURA) Assets Average (2011 - 2026)
TuHURA Biosciences (HURA) posted quarterly Assets Average of $28.5 million for Q1 2026, up 64.88% year-over-year from $17.3 million in Q1 2025, and up 7.55% quarter-over-quarter from $26.5 million in Q4 2025.
TuHURA Biosciences (HURA) Assets Average (2011 - 2026) Analysis & Trends
TuHURA Biosciences' Assets Average history runs 16 years deep, the most recent figure standing at $28.5 million for Q1 2026.
- In Q1 2026, Assets Average rose 64.88% year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $28.5 million (up 64.88% YoY), while the FY2025 annual figure was $23.7 million, up 80.83% from the prior year.
- Assets Average for Q1 2026 stood at $28.5 million, up from $26.5 million in the prior quarter.
- The five-year high for Assets Average was $30.2 million in Q3 2025, with the low at $2.7 million in Q3 2023.
- The 5-year median for Assets Average is $12.1 million (2024), against an average of $13.7 million.
- The sharpest annual moves came in 2023 and 2025: Assets Average tumbled 81.29% in 2023, then surged 483.24% in 2025.
- TuHURA Biosciences' Assets Average stood at $11.6 million in 2022, then slumped by 74.75% to $2.9 million in 2023, then jumped by 312.87% to $12.1 million in 2024, then jumped by 120.06% to $26.5 million in 2025, then gained by 7.55% to $28.5 million in 2026.
- Business Quant data shows HURA's Assets Average at $28.5 million in Q1 2026, $26.5 million in Q4 2025, and $30.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 30.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.53 Mn |
| Dec 31, 2025 | 26.53 Mn |
| Sep 30, 2025 | 30.16 Mn |
| Jun 30, 2025 | 24.63 Mn |
| Mar 31, 2025 | 17.30 Mn |
| Dec 31, 2024 | 12.05 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 6.82 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 8.33 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 14.58 Mn |
| Jun 30, 2022 | 14.37 Mn |
| Mar 31, 2022 | 15.26 Mn |
| Dec 31, 2021 | 20.03 Mn |
| Sep 30, 2021 | 17.94 Mn |
| Jun 30, 2021 | 16.20 Mn |